Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 20, 2025 21:11 ET | Source: Shenzhen Hengsheng Hospital

Latest breakthrough in Type 1 diabetes treatment: Chinese medical team enables 24 patients to discontinue insulin use

SHENZHEN, China, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital, China, announced a groundbreaking achievement: since June 2024,...
August 20, 2025 19:30 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Global Enzymes Market Set to Reach $20.4 Billion by 2029 | Asia-Pacific Emerges as a Hotspot

Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets, the global enzymes market is experiencing robust growth, driven by innovations in biotechnology, increasing demand...
August 20, 2025 16:03 ET | Source: NurExone Biologic Inc

NurExone Biologic Announces Preclinical Evidence of Structural Repair in Injured Spinal Cord Tissue following ExoPTEN Treatment

TORONTO and HAIFA, Israel, Aug. 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce new preclinical imaging...
August 20, 2025 16:01 ET | Source: Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity

– U.S. Food and Drug Administration accepts sNDA for filing with priority review; sets PDUFA goal date of December 20, 2025 -- – European Medicines Agency accepts and validates submission for Type II...
August 20, 2025 13:44 ET | Source: Utah Valley University

From Utah to Peru: UVU Water Scientists Lead Fight Against Contamination

Orem, Utah, Aug. 20, 2025 (GLOBE NEWSWIRE) -- In a remote hotel room near Lima, Peru, Dr. Lauren Brooks worked through the night, hunched over buckets and sterilization tablets, testing water...
August 20, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Merkel Cell Carcinoma Market Set for Rapid Growth in the Coming 10 Years Across the 7MM | DelveInsight

New York, USA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Merkel Cell Carcinoma Market Set for Rapid Growth in the Coming 10 Years Across the 7MM | DelveInsight The market size of Merkel cell carcinoma in...
August 20, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Global Big Data in Healthcare Market is Predicted to Cross the USD 330 Billion Mark by 2032 | DelveInsight

New York, USA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Global Big Data in Healthcare Market is Predicted to Cross the USD 330 Billion Mark by 2032 | DelveInsight The demand for big data in healthcare is...
August 20, 2025 12:54 ET | Source: King Faisal Specialist Hospital & Research Centre

King Faisal Specialist Hospital Provides Nearly 300,000 Virtual Consultations in 2024

RIYADH, Saudi Arabia, Aug. 20, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) delivered 293,381 virtual clinic visits in 2024, a 58.2% increase from the...
August 20, 2025 11:33 ET | Source: BioAegis Therapeutics

BioAegis Therapeutics Awarded Second FDA Fast Track Designation for Recombinant Human Gelsolin to Treat Inflammasome-Driven Decompression Sickness (DCS)

Fast Track status accelerates regulatory pathway for BioAegis’ recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases. Second Fast Track designation in...
August 20, 2025 11:19 ET | Source: Regeneron Pharmaceuticals, Inc.

EYLEA HD® (aflibercept) Injection 8 mg Applications for Expanded U.S. Label and Prefilled Syringe Receive FDA Review Period Extension

TARRYTOWN, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has extended the target action...